Table 2.
Demographic and Clinical Characteristics at Enrollment of 3,882 Eligiblea Patients at 8 Clinical Sites, Who Entered Treatment Between January 1, 1998, and December 31, 2014, and Were Followed for Mortality for up to 10 Years, Centers for AIDS Research Network of Integrated Clinical Systems, United States
| Characteristic | At CNICS Enrollment (n = 3,882) | |
|---|---|---|
| No. of Patients | % | |
| Male sex | 3,193 | 82 |
| Black race | 1,338 | 34 |
| Hispanic ethnicity | 334 | 9 |
| Injection-drug user | 500 | 13 |
| MSM | 2,635 | 68 |
| AIDS | 215 | 6 |
| Age group, years | ||
| 18–30 | 1,272 | 33 |
| 31–50 | 2,277 | 59 |
| >50 | 333 | 9 |
| CD4 cell count at entry | ||
| 500–600 | 1,411 | 36 |
| 601–750 | 1,293 | 33 |
| 751–1,000 | 881 | 23 |
| >1,000 | 297 | 8 |
| CD4 cell count at ART | ||
| 0–200 | 100 | 3 |
| 201–350 | 287 | 7 |
| 351–500 | 393 | 10 |
| >500 | 1,309 | 34 |
| Did not initiate ART while in the study | 1,793 | 46 |
| Year of CNICS enrollment | ||
| 1998–2002 | 1,062 | 27 |
| 2003–2007 | 1,179 | 30 |
| 2008–2014 | 1,641 | 42 |
Abbreviations: AIDS, acquired immune deficiency syndrome; ART, antiretroviral therapy; CNICS, Centers for AIDS Research Network of Integrated Clinical Systems; MSM, men who have sex with men.
a Eligible patients were ART-naive, virally unsuppressed patients who were linked to care at a CNICS site with an initial CD4 cell count above 500 cells/mm3.